The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Veronica MorozDavid MachinBarbara HeroRuth LadensteinFrank BertholdPaige KaoYaa ObengAndrew D J PearsonSusan L CohnWendy B LondonPublished in: Pediatric blood & cancer (2020)
LDH and ferritin are strongly prognostic in NB, overall and within high-risk NB patients treated post-2009 with modern therapy. LDH and ferritin show promise for (a) identifying ultra-high-risk; (b) refining risk stratification; and (c) clinical utility in low-/middle-income countries. Routine collection of LDH and ferritin should be reinitiated for evolving NB risk stratification.